VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2023 Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2023 Earnings Call Transcript February 10, 2023

Operator: Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note, this conference is being recorded. I will now turn the conference over to Mark Flather, Vice President of Investor Relations. Thank you. You may begin.

Mark...